Testing a new insulin for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a new weekly insulin called GZR4 for people with type 2 diabetes who already use basal insulin. It aims to see how well it controls blood sugar and if it is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with type 2 diabetes for at least 6 months
- Currently taking basal insulin once or twice daily, or weekly insulin Icodec
- Age 18 or older
- Must use reliable birth control if there is any chance of pregnancy, and for 3 weeks after treatment ends
- No serious heart problems, like recent heart attack or heart failure, in the last 6 months
- No history of cancer in the past 5 years (except some easily treated skin cancers)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests a new medicine called RZ-629. It looks at how safe it is, how the body processes it, and how it works in both healthy people and people with type 2 diabetes. If you have diabetes, you can join if your blood sugar is well controlled on your current pills.
This study tests a new once-daily injection (LC-Z300-01) to see if it can lower blood sugar safely in people with type 2 diabetes. It may be a good option if your current diabetes medications aren't controlling your blood sugar as well as you'd like.
This study tests if a new insulin injection made with different manufacturing methods works the same in the body. Healthy men aged 18-50 can join to help check if the new versions are as good as the original.
This trial tests an experimental insulin (GZR101-80) to see if it helps control blood sugar in people with type 2 diabetes. You may join if you’ve had type 2 diabetes for at least 6 months and are between 18 and 75 years old.
This study tests a new once-daily insulin (GZR4) against an approved insulin (degludec) in people with type 2 diabetes to see how well it controls blood sugar. You may qualify if you are already using a stable dose of background insulin.
This study tests a new injectable medication called GZR33 to help control blood sugar in people with type 2 diabetes who are already taking oral diabetes pills. The trial will measure how well it works and how safe it is.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.